09/05/2024 3:06 PM | Disc Medicine, Inc. (Issuer) Disc Medicine (Issuer) White William Richard (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/08/2024 8:23 AM | Disc Medicine, Inc. (Filer) Disc Medicine (Filer)
| Form S-3ASR | |
08/08/2024 7:06 AM | Disc Medicine, Inc. (Filer) Disc Medicine (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/08/2024 7:15 AM | Disc Medicine, Inc. (Filer) Disc Medicine (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/01/2024 4:10 PM | Disc Medicine, Inc. (Subject) Disc Medicine (Subject) White William Richard (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2024 3:15 PM | Disc Medicine, Inc. (Issuer) Disc Medicine (Issuer) Quisel John D (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 9:06 AM | Disc Medicine, Inc. (Subject) Disc Medicine (Subject) Frazier Life Sciences Public Fund, L.P. (Filed by)
| Form SC 13G | |
|
06/20/2024 7:00 PM | Bitterman Kevin (Reporting) Disc Medicine, Inc. (Issuer) Disc Medicine (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/20/2024 4:27 PM | Ashiya Mona (Reporting) Disc Medicine, Inc. (Issuer) Disc Medicine (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/20/2024 4:19 PM | Disc Medicine, Inc. (Issuer) Disc Medicine (Issuer) ORBIMED ADVISORS LLC (Reporting) OrbiMed Capital GP VI LLC (Reporting) OrbiMed Capital GP VIII LLC (Reporting) OrbiMed Genesis GP LLC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/20/2024 4:15 PM | Disc Medicine, Inc. (Subject) Disc Medicine (Subject) ORBIMED ADVISORS LLC (Filed by)
| Form SC 13D/A | |
06/14/2024 6:36 AM | Disc Medicine, Inc. (Filer) Disc Medicine (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/09/2024 7:15 AM | Disc Medicine, Inc. (Filer) Disc Medicine (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/09/2024 7:07 AM | Disc Medicine, Inc. (Filer) Disc Medicine (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/03/2024 3:05 PM | Disc Medicine, Inc. (Issuer) Disc Medicine (Issuer) White William Richard (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/15/2024 5:27 PM | Disc Medicine, Inc. (Issuer) Disc Medicine (Issuer) White William Richard (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/11/2024 4:02 PM | Disc Medicine, Inc. (Issuer) Disc Medicine (Issuer) Savage William Jacob (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/11/2024 3:14 PM | Disc Medicine, Inc. (Subject) Disc Medicine (Subject) White William Richard (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/02/2024 4:25 PM | Disc Medicine, Inc. (Filer) Disc Medicine (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/21/2024 7:54 AM | Disc Medicine, Inc. (Filer) Disc Medicine (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/21/2024 7:00 AM | Disc Medicine, Inc. (Filer) Disc Medicine (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/21/2024 7:15 AM | Disc Medicine, Inc. (Filer) Disc Medicine (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/07/2024 3:40 PM | Bitterman Kevin (Reporting) Disc Medicine, Inc. (Issuer) Disc Medicine (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 5:45 PM | Atlas Venture Fund X, L.P. (Reporting) Disc Medicine, Inc. (Subject) Disc Medicine (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024 5:47 PM | Atlas Venture Opportunity Fund I, L.P. (Reporting) Disc Medicine, Inc. (Subject) Disc Medicine (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024 6:36 PM | Disc Medicine, Inc. (Issuer) Disc Medicine (Issuer) Savage William Jacob (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/01/2024 6:38 PM | Disc Medicine, Inc. (Issuer) Disc Medicine (Issuer) Yu Jonathan Yen-Wen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/01/2024 6:39 PM | Disc Medicine, Inc. (Issuer) Disc Medicine (Issuer) Khara Rahul (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/01/2024 6:42 PM | Disc Medicine, Inc. (Issuer) Disc Medicine (Issuer) Quisel John D (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/01/2024 6:49 PM | Bryce Joanne (Reporting) Disc Medicine, Inc. (Issuer) Disc Medicine (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2024 4:38 PM | Disc Medicine, Inc. (Issuer) Disc Medicine (Issuer) Stephenson Pamela (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2024 4:33 PM | Disc Medicine, Inc. (Issuer) Disc Medicine (Issuer) Stephenson Pamela (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
02/26/2024 7:43 AM | Disc Medicine, Inc. (Filer) Disc Medicine (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/15/2024 7:33 PM | Disc Medicine, Inc. (Issuer) Disc Medicine (Issuer) Franchi Jean M. (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
02/15/2024 7:37 PM | Disc Medicine, Inc. (Issuer) Disc Medicine (Issuer) Franchi Jean M. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2024 5:51 PM | Bain Capital Life Sciences Opportunities III, LP (Filed by) Disc Medicine, Inc. (Subject) Disc Medicine (Subject)
| Form SC 13G/A | |
02/09/2024 7:50 AM | Disc Medicine, Inc. (Subject) Disc Medicine (Subject) FMR LLC (Filed by)
| Form SC 13G/A | |
02/07/2024 7:10 AM | Disc Medicine, Inc. (Filer) Disc Medicine (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/07/2024 6:24 AM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by) Disc Medicine, Inc. (Subject) Disc Medicine (Subject)
| Form SC 13G/A | |
02/06/2024 3:55 PM | Disc Medicine, Inc. (Subject) Disc Medicine (Subject) MacDonald Brian Richard (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/23/2024 4:44 PM | Atlas Venture Fund X, L.P. (Reporting) Disc Medicine, Inc. (Subject) Disc Medicine (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
What is Nvidia’s New $1 Trillion SuperProject? (Ad) Taiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as 4,744%.
Now, if you’re like everybody else, you want to know what Nvidia’s doing next … and who they’re going to partner with …![](https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=9285&Placement=NativeDisplay&Source=NativeDisplay) Find out details on these three critical Nvidia partners immediately. |
01/23/2024 4:47 PM | Atlas Venture Opportunity Fund I, L.P. (Reporting) Disc Medicine, Inc. (Subject) Disc Medicine (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/23/2024 4:48 PM | Atlas Venture Opportunity Fund II, L.P. (Reporting) Disc Medicine, Inc. (Subject) Disc Medicine (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/12/2024 4:12 PM | Atlas Venture Associates Opportunity I, L.P. (Reporting) Atlas Venture Associates Opportunity I, LLC (Reporting) ATLAS VENTURE ASSOCIATES X, L.P. (Reporting) Atlas Venture Associates X, LLC (Reporting) Atlas Venture Fund X, L.P. (Reporting) Atlas Venture Opportunity Fund I, L.P. (Reporting) Disc Medicine, Inc. (Issuer) Disc Medicine (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/12/2024 4:12 PM | Bitterman Kevin (Reporting) Disc Medicine, Inc. (Issuer) Disc Medicine (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/10/2024 8:44 PM | Atlas Venture Fund X, L.P. (Reporting) Disc Medicine, Inc. (Subject) Disc Medicine (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/10/2024 8:51 PM | Atlas Venture Opportunity Fund I, L.P. (Reporting) Disc Medicine, Inc. (Subject) Disc Medicine (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/04/2024 3:24 PM | Disc Medicine, Inc. (Subject) Disc Medicine (Subject) MacDonald Brian Richard (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/29/2023 3:15 PM | Bryce Joanne (Reporting) Disc Medicine, Inc. (Issuer) Disc Medicine (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/20/2023 5:16 PM | Ashiya Mona (Reporting) Disc Medicine, Inc. (Issuer) Disc Medicine (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/20/2023 5:28 PM | Disc Medicine, Inc. (Issuer) Disc Medicine (Issuer) ORBIMED ADVISORS LLC (Reporting) OrbiMed Capital GP VI LLC (Reporting) OrbiMed Capital GP VIII LLC (Reporting) OrbiMed Genesis GP LLC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/15/2023 5:04 PM | Disc Medicine, Inc. (Issuer) Disc Medicine (Issuer) ORBIMED ADVISORS LLC (Reporting) OrbiMed Capital GP VI LLC (Reporting) OrbiMed Capital GP VIII LLC (Reporting) OrbiMed Genesis GP LLC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/15/2023 5:09 PM | Ashiya Mona (Reporting) Disc Medicine, Inc. (Issuer) Disc Medicine (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/15/2023 5:11 PM | Disc Medicine, Inc. (Subject) Disc Medicine (Subject) ORBIMED ADVISORS LLC (Reporting)
| Form 144/A | |
12/15/2023 5:15 PM | Disc Medicine, Inc. (Subject) Disc Medicine (Subject) ORBIMED ADVISORS LLC (Reporting)
| Form 144/A | |
12/15/2023 5:18 PM | Disc Medicine, Inc. (Subject) Disc Medicine (Subject) ORBIMED ADVISORS LLC (Reporting)
| Form 144/A | |
12/15/2023 3:48 PM | Disc Medicine, Inc. (Subject) Disc Medicine (Subject) ORBIMED ADVISORS LLC (Filed by)
| Form SC 13D/A | |
12/14/2023 7:13 PM | Atlas Venture Associates Opportunity I, L.P. (Reporting) Atlas Venture Associates Opportunity I, LLC (Reporting) ATLAS VENTURE ASSOCIATES X, L.P. (Reporting) Atlas Venture Associates X, LLC (Reporting) Atlas Venture Fund X, L.P. (Reporting) Atlas Venture Opportunity Fund I, L.P. (Reporting) Disc Medicine, Inc. (Issuer) Disc Medicine (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/14/2023 7:14 PM | Bitterman Kevin (Reporting) Disc Medicine, Inc. (Issuer) Disc Medicine (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/14/2023 4:40 PM | Ashiya Mona (Reporting) Disc Medicine, Inc. (Issuer) Disc Medicine (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/14/2023 4:44 PM | Disc Medicine, Inc. (Issuer) Disc Medicine (Issuer) ORBIMED ADVISORS LLC (Reporting) OrbiMed Capital GP VI LLC (Reporting) OrbiMed Capital GP VIII LLC (Reporting) OrbiMed Genesis GP LLC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/14/2023 3:15 PM | Bryce Joanne (Reporting) Disc Medicine, Inc. (Issuer) Disc Medicine (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/14/2023 3:15 PM | Disc Medicine, Inc. (Issuer) Disc Medicine (Issuer) White William Richard (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/12/2023 4:53 PM | Disc Medicine, Inc. (Subject) Disc Medicine (Subject) ORBIMED ADVISORS LLC (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/12/2023 4:58 PM | Disc Medicine, Inc. (Subject) Disc Medicine (Subject) ORBIMED ADVISORS LLC (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/12/2023 5:00 PM | Atlas Venture Opportunity Fund I, L.P. (Reporting) Disc Medicine, Inc. (Subject) Disc Medicine (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/12/2023 5:03 PM | Atlas Venture Fund X, L.P. (Reporting) Disc Medicine, Inc. (Subject) Disc Medicine (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/12/2023 4:42 PM | Disc Medicine, Inc. (Subject) Disc Medicine (Subject) ORBIMED ADVISORS LLC (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/12/2023 3:19 PM | Bryce Joanne (Reporting) Disc Medicine, Inc. (Subject) Disc Medicine (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/12/2023 3:19 PM | Disc Medicine, Inc. (Subject) Disc Medicine (Subject) White William Richard (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/11/2023 7:35 PM | Disc Medicine, Inc. (Filer) Disc Medicine (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/11/2023 11:11 AM | Disc Medicine, Inc. (Filer) Disc Medicine (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/06/2023 11:15 PM | Disc Medicine, Inc. (Filer) Disc Medicine (Filer)
| Form EFFECT | |
12/05/2023 3:51 PM | Disc Medicine, Inc. (Filer) Disc Medicine (Filer)
| Form 424B5 | |
12/05/2023 3:53 PM | Disc Medicine, Inc. (Filer) Disc Medicine (Filer)
| Form POS AM | |
12/05/2023 3:53 PM | Disc Medicine, Inc. (Filer) Disc Medicine (Filer)
| Form POS AM | |
12/05/2023 3:21 PM | Bryce Joanne (Reporting) Disc Medicine, Inc. (Subject) Disc Medicine (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/29/2023 11:15 PM | Disc Medicine, Inc. (Filer) Disc Medicine (Filer)
| Form EFFECT | |
11/22/2023 3:18 PM | Disc Medicine, Inc. (Subject) Disc Medicine (Subject) Khara Rahul (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/13/2023 5:46 AM | AI DMI LLC (Filed by) Disc Medicine, Inc. (Subject) Disc Medicine (Subject)
| Form SC 13D/A | |
11/09/2023 7:35 AM | Disc Medicine, Inc. (Filer) Disc Medicine (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/09/2023 7:45 AM | Disc Medicine, Inc. (Filer) Disc Medicine (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/07/2023 5:22 PM | Disc Medicine, Inc. (Issuer) Disc Medicine (Issuer) Khara Rahul (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/03/2023 3:23 PM | Disc Medicine, Inc. (Subject) Disc Medicine (Subject) Khara Rahul (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/02/2023 8:05 AM | Disc Medicine, Inc. (Filer) Disc Medicine (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/23/2023 8:15 AM | Disc Medicine, Inc. (Filer) Disc Medicine (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/10/2023 3:38 PM | Disc Medicine, Inc. (Filer) Disc Medicine (Filer)
| Form 424B5 | |
10/10/2023 3:40 PM | Disc Medicine, Inc. (Filer) Disc Medicine (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/29/2023 3:06 PM | Disc Medicine, Inc. (Filer) Disc Medicine (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/25/2023 3:56 PM | Disc Medicine, Inc. (Subject) Disc Medicine (Subject) Paradigm Biocapital Advisors LP (Filed by)
| Form SC 13G | |
09/21/2023 3:44 PM | Atlas Venture Fund X, L.P. (Filed by) Disc Medicine, Inc. (Subject) Disc Medicine (Subject)
| Form SC 13D/A | |
What is Nvidia’s New $1 Trillion SuperProject? (Ad) Taiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as 4,744%.
Now, if you’re like everybody else, you want to know what Nvidia’s doing next … and who they’re going to partner with …![](https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=9285&Placement=NativeDisplay&Source=NativeDisplay) Find out details on these three critical Nvidia partners immediately. |
09/18/2023 3:59 PM | Disc Medicine, Inc. (Issuer) Disc Medicine (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/15/2023 5:44 PM | Atlas Venture Fund X, L.P. (Reporting) Disc Medicine, Inc. (Subject) Disc Medicine (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/14/2023 4:32 PM | Atlas Venture Fund X, L.P. (Reporting) Disc Medicine, Inc. (Subject) Disc Medicine (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/13/2023 3:15 PM | Bryce Joanne (Reporting) Disc Medicine, Inc. (Issuer) Disc Medicine (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |